Similar articles for PMID: 31519801

Year	Number of Results
1998	1
2003	1
2004	1
2006	1
2009	4
2010	8
2011	2
2012	5
2013	7
2014	10
2015	12
2016	14
2017	20
2018	17
2019	14
2020	17
2021	19
2022	23
2023	27
2024	14

1

PET-Based Human Dosimetry of ⁶⁸Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging.

Boss M, Buitinga M, Jansen TJP, Brom M, Visser EP, Gotthardt M. Boss M, et al. J Nucl Med. 2020 Jan;61(1):112-116. doi: 10.2967/jnumed.119.228627. Epub 2019 Sep 13. J Nucl Med. 2020. PMID: 31519801 Free PMC article.

2

A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of ⁶⁸Ga-NODAGA-LM3 and ⁶⁸Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors.

Zhu W, Cheng Y, Jia R, Zhao H, Bai C, Xu J, Yao S, Huo L. Zhu W, et al. J Nucl Med. 2021 Oct;62(10):1398-1405. doi: 10.2967/jnumed.120.253096. Epub 2021 Feb 12. J Nucl Med. 2021. PMID: 33579804 Free PMC article. Clinical Trial.

3

First-in-Humans Study of ⁶⁸Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1.

Viitanen R, Moisio O, Lankinen P, Li XG, Koivumäki M, Suilamo S, Tolvanen T, Taimen K, Mali M, Kohonen I, Koskivirta I, Oikonen V, Virtanen H, Santalahti K, Autio A, Saraste A, Pirilä L, Nuutila P, Knuuti J, Jalkanen S, Roivainen A. Viitanen R, et al. J Nucl Med. 2021 Apr;62(4):577-583. doi: 10.2967/jnumed.120.250696. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817143 Free PMC article.

4

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [⁶⁸Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method.

Migliari S, Sammartano A, Boss M, Gotthardt M, Scarlattei M, Baldari G, Silva C, Bonadonna RC, Ruffini L. Migliari S, et al. Molecules. 2022 Jan 15;27(2):543. doi: 10.3390/molecules27020543. Molecules. 2022. PMID: 35056858 Free PMC article.

5

Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.

Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, Myschetzky R, El-Ali HH, Madsen J, Kjaer A. Oxboel J, et al. Nucl Med Biol. 2014 Mar;41(3):259-67. doi: 10.1016/j.nucmedbio.2013.12.003. Epub 2013 Dec 12. Nucl Med Biol. 2014. PMID: 24417983 Free article.

6

64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.

Mikkola K, Yim CB, Fagerholm V, Ishizu T, Elomaa VV, Rajander J, Jurttila J, Saanijoki T, Tolvanen T, Tirri M, Gourni E, Béhé M, Gotthardt M, Reubi JC, Mäcke H, Roivainen A, Solin O, Nuutila P. Mikkola K, et al. Mol Imaging Biol. 2014 Apr;16(2):255-63. doi: 10.1007/s11307-013-0691-2. Mol Imaging Biol. 2014. PMID: 24101374 Free article.

7

Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.

Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M. Herrmann K, et al. J Nucl Med. 2015 Mar;56(3):410-6. doi: 10.2967/jnumed.114.151647. Epub 2015 Feb 19. J Nucl Med. 2015. PMID: 25698782 Free article.

8

Preliminary results of biodistribution and dosimetric analysis of [⁶⁸Ga]Ga-DOTA^ZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases.

Khawar A, Eppard E, Roesch F, Ahmadzadehfar H, Kürpig S, Meisenheimer M, Gaertner FC, Essler M, Bundschuh RA. Khawar A, et al. Ann Nucl Med. 2019 Jun;33(6):404-413. doi: 10.1007/s12149-019-01348-7. Epub 2019 Mar 15. Ann Nucl Med. 2019. PMID: 30877560

9

Glucagon-like peptide-1 receptor expression after myocardial infarction: Imaging study using ⁶⁸Ga-NODAGA-exendin-4 positron emission tomography.

Ståhle M, Kytö V, Kiugel M, Liljenbäck H, Metsälä O, Käkelä M, Li XG, Oikonen V, Saukko P, Nuutila P, Knuuti J, Roivainen A, Saraste A. Ståhle M, et al. J Nucl Cardiol. 2020 Dec;27(6):2386-2397. doi: 10.1007/s12350-018-01547-1. Epub 2018 Dec 13. J Nucl Cardiol. 2020. PMID: 30547299 Free PMC article.

10

Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D. Nicolas GP, et al. J Nucl Med. 2018 Jun;59(6):909-914. doi: 10.2967/jnumed.117.199737. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025985 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31519801

185 results

Results by year